Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Johnson & Johnson

www.jnj.com

Latest From Johnson & Johnson

Drug Price Waterloo: China's New Bidding Process Hits MNCs Hard

China's new so-called “4+7” drug bidding pilot scheme, already expected to be a killer for some companies, has cut prices by as much as 90%, leaving all but two multinationals to bid successfully and accept the revised levels. The big reductions could also lead to further price erosion for the winning products.

China Commercial

China Reg Express: Gilead, Roche Bag Descovy, Hemlibra OKs, NMPA Joins COPP

China continues approvals rush, granting green lights for Harvoni, Descovy and Hemlibra, and expands Zytiga's use. Meanwhile, the nation’s top regulatory agency signs an MoU with the Medicines Patent Pool and joins the COPP program.

China Approvals

Actelion Is Third Company To Settle Charity Co-Pay Kickback Claims With DOJ

Company agrees to pay $360m to resolve allegations it used a charity as a conduit to pay Medicare patient copays for its drugs; several other companies are under investigation.

Policy Enforcement

AML Paradigm Shift: Doctors Welcome Many New Approvals And Approaches

This year's ASH meeting reflected a peak of development success, with many new approvals and many more in the pipeline.

Clinical Trials Cancer
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register